EPX-HTG for Structural Heart Procedures
This study is looking at how a new visualization tool, EchoPixel Holographic Therapy Guidance (HTG), can improve common heart procedures. These procedures include Left Atrial Appendage Occlusion (LAAO), which helps prevent strokes in people with Atrial Fibrillation (an irregular heartbeat), and Mitral Valve Transcatheter Edge to Edge Repair (M-TEER), which fixes a leaky heart valve (Mitral Valve Regurgitation). The study wants to see if adding HTG to the usual imaging methods helps doctors place devices more accurately. You may be able to join if you are 18 or older and are already scheduled for an LAAO or M-TEER procedure at the study site using specific Philips ultrasound equipment. The main goal is to see if HTG helps achieve the best possible device position, measured 45 days after your procedure. The current status of this study is unclear.
- Study design
- This is an interventional study involving 20 participants. It is a prospective, single-center clinical chart review.
- What's involved
- The study will review your medical records, including pre-procedure CT scans, procedural ultrasound images (TEE or ICE), fluoroscopic imaging, and post-device implant images. Data will be collected on case report forms.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your optimal device position will be measured 45 days after the procedure.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
EPX-HTG for Structural Heart Procedures
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Gagan D Singh, MD · PRINCIPAL_INVESTIGATOR · UC Davis Health
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Optimal Device Position.45 days post procedure.
For both LAAO and M-TEER procedures an optimal device position will be established in pre-procedure planning. The optimal device position will be evaluated at the time of the procedure and in post-procedure imaging.